Kasajima Atsuko, Cameselle-Teijeiro José, Loidi Lourdes, Takahashi Yoshio, Nakashima Noriaki, Sato Satoko, Fujishima Fumiyoshi, Watanabe Mika, Nakazawa Tadao, Naganuma Hiroshi, Kondo Tetsuo, Kato Ryohei, Sasano Hironobu
Department of Pathology, Tohoku University Hospital, Sendai, Japan.
Department of Pathology, Clinical University Hospital, SERGAS, Faculty of Medicine, University of Santiago de Compostela, 15705, Santiago de Compostela, Spain.
Endocr Pathol. 2016 Dec;27(4):325-331. doi: 10.1007/s12022-016-9416-9.
Neuroendocrine tumors of the thyroid gland are generally considered to derive from parafollicular endocrine cells (C cells) and are generally referred to as medullary thyroid carcinomas (MTC). Calcitonin secretion is almost always detected in MTC and a prerequisite for both clinical and pathological diagnosis. Thyroid neuroendocrine tumors without any apparent calcitonin secretion reflect a diagnostic dilemma because non-calcitonin-producing MTCs have virtually not been characterized. Here, we report a case of primary thyroid neuroendocrine tumors lacking calcitonin secretion or expression. The tumor cells expressed cytokeratins, chromogranin A, and synaptophysin, all of which were consistent with epithelial and neuroendocrine differentiation. Thyroid transcription factor-1 paired box gene 8, and carcinoembryonic antigen were also immunohistochemically detected, consistent with its thyroid origin. However, the tumor was negative for calcitonin both by immunohistochemistry and in situ hybridization, hence, not meeting the definition of MTC. Despite the loss of calcitonin expression, immunoreactivity for the calcitonin-gene-related peptide was detected in the tumor. Somatic gene mutations of RET, H-RAS, K-RAS, or BRAF were not detected in this case. A limited number of calcitonin non-producing thyroid neuroendocrine tumors are available in the scientific literature available in English, and its etiology and clinical manifestations remain largely unknown. Our case, along with the rare, previously reported cases, suggests that calcitonin non-producing neuroendocrine tumors of the thyroid gland are most likely derived from C cells, but should be differentiated from ordinary MTCs.
甲状腺神经内分泌肿瘤通常被认为起源于滤泡旁内分泌细胞(C细胞),一般被称为甲状腺髓样癌(MTC)。在MTC中几乎总能检测到降钙素分泌,这是临床和病理诊断的前提条件。没有任何明显降钙素分泌的甲状腺神经内分泌肿瘤反映了一个诊断难题,因为不产生降钙素的MTC实际上尚未得到明确特征描述。在此,我们报告一例缺乏降钙素分泌或表达的原发性甲状腺神经内分泌肿瘤病例。肿瘤细胞表达细胞角蛋白、嗜铬粒蛋白A和突触素,所有这些均与上皮和神经内分泌分化一致。甲状腺转录因子-1、配对盒基因8和癌胚抗原也通过免疫组织化学检测到,与其甲状腺起源一致。然而,该肿瘤通过免疫组织化学和原位杂交检测降钙素均为阴性,因此不符合MTC的定义。尽管降钙素表达缺失,但在肿瘤中检测到了降钙素基因相关肽的免疫反应性。该病例未检测到RET、H-RAS、K-RAS或BRAF的体细胞基因突变。英文科学文献中报道的不产生降钙素的甲状腺神经内分泌肿瘤数量有限,其病因和临床表现仍 largely未知。我们的病例以及先前报道的罕见病例表明,不产生降钙素的甲状腺神经内分泌肿瘤很可能起源于C细胞,但应与普通MTC相鉴别。